{"altmetric_id":1783193,"counts":{"readers":{"mendeley":17,"citeulike":0,"connotea":0},"total":{"posts_count":8},"twitter":{"unique_users_count":8,"unique_users":["1MEDICAL2NEWS","ScripMikeWard","scripnews","BioWizzard","Editage","SummertownStars","CMRO_Journal","scriptmedical"],"posts_count":8}},"selected_quotes":["\u201c@CMRO_Journal: Early use of GLP-1 receptor agonists in Type 2 diabetes: Current Medical Researc... #pharma #biotech","New pub: Early use of glucagon-like peptide-1 receptor agonists in Type 2 diabetes: - already 150 copies downloaded"],"citation":{"abstract":"To evaluate the efficacy and safety of the available glucagon-like peptide-1 receptor agonists (GLP-1 RAs) exenatide and liraglutide (marketed as Byetta * and Victoza \u2020 , respectively) in first- or second-line pharmacotherapy for type 2 diabetes (T2D), described here as 'early use'.","abstract_source":"pubmed","altmetric_jid":"4f6fa4eb3cf058f610002692","authors":["Stuart A. Ross","Jane Ballantine"],"doi":"10.1185\/03007995.2013.837817","endpage":"10","first_seen_on":"2013-09-26T03:15:24+00:00","issns":["0300-7995","1473-4877"],"journal":"Current Medical Research & Opinion","last_mentioned_on":1380226687,"links":["http:\/\/informahealthcare.com\/doi\/abs\/10.1185\/03007995.2013.837817","http:\/\/informahealthcare.com\/doi\/abs\/10.1185\/03007995.2013.837817?prevSearch=&searchHistoryKey=&","http:\/\/informahealthcare.com\/doi\/abs\/10.1185\/03007995.2013.837817?ai=845&mi=3b4gaf&af=R&","http:\/\/informahealthcare.com\/doi\/abs\/10.1185\/03007995.2013.837817?ai=845&mi=3b6bd2&af=R&utm_source=twitterfeed&utm_medium=twitter&"],"pmid":"23971789","pubdate":"2013-09-25T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Economics","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1","subjects":["medicine"],"title":"Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/early-glucagonlike-peptide1-receptor-agonists-glp1-ras-type-2-diabetes"},"altmetric_score":{"score":5.55,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.55},"context_for_score":{"all":{"total_number_of_other_articles":4508238,"mean":5.1674528195662,"rank":679613,"this_scored_higher_than_pct":84,"this_scored_higher_than":3825971,"rank_type":"exact","sample_size":4508238,"percentile":84},"similar_age_3m":{"total_number_of_other_articles":98037,"mean":7.8397091476603,"rank":18411,"this_scored_higher_than_pct":81,"this_scored_higher_than":79524,"rank_type":"exact","sample_size":98037,"percentile":81},"this_journal":{"total_number_of_other_articles":1124,"mean":2.096589492431,"rank":74,"this_scored_higher_than_pct":93,"this_scored_higher_than":1050,"rank_type":"exact","sample_size":1124,"percentile":93},"similar_age_this_journal_3m":{"total_number_of_other_articles":86,"mean":2.0053411764706,"rank":5,"this_scored_higher_than_pct":94,"this_scored_higher_than":81,"rank_type":"exact","sample_size":86,"percentile":94}}},"demographics":{"poster_types":{"member_of_the_public":4,"practitioner":3,"science_communicator":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":3,"Members of the public":4,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":4,"Student  > Postgraduate":5,"Other":3,"Student  > Master":3,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":13,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":3}}},"geo":{"twitter":{"US":1,"GB":2,"CA":1},"mendeley":{"BR":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/1MEDICAL2NEWS\/status\/383093044452798464","license":"public","rt":["CMRO_Journal"],"citation_ids":[1783193],"posted_on":"2013-09-26T04:57:53+00:00","author":{"name":"Dr. Richard Billard","image":"http:\/\/pbs.twimg.com\/profile_images\/3132628093\/598a314465db0e9aab2e00cb29cf6aa6_normal.jpeg","description":"Latest breaking medical news and information tweeted and retweeted 24\/7.","id_on_source":"1MEDICAL2NEWS","tweeter_id":"1105523178","geo":{"lt":"34.0536781","ln":"-118.2427025","country":"US"},"followers":670},"tweet_id":"383093044452798464"},{"url":"http:\/\/twitter.com\/ScripMikeWard\/status\/383107591897104384","license":"public","citation_ids":[1783193],"posted_on":"2013-09-26T05:55:42+00:00","author":{"name":"Mike Ward","url":"http:\/\/www.scripintelligence.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000308429980\/0288ff3098daceff8672357bac3209fd_normal.jpeg","description":"Chief Content Officer at Datamonitor Healthcare & Scrip Intelligence commentating on issues consequential to pharma, biotech, healthcare & medtech stakeholders","id_on_source":"ScripMikeWard","tweeter_id":"243228907","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":4670},"tweet_id":"383107591897104384"},{"url":"http:\/\/twitter.com\/scripnews\/status\/383322971546607616","license":"public","rt":["ScripMikeWard"],"citation_ids":[1783193],"posted_on":"2013-09-26T20:11:32+00:00","author":{"name":"Scrip","url":"https:\/\/scrip.pharmamedtechbi.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/705042447504642048\/DDzsngqo_normal.jpg","description":"Scrip goes beyond the headlines and focuses on delivering insight & analysis on the whole of the drug discovery, development and product life cycle value chain.","id_on_source":"scripnews","tweeter_id":"21079030","geo":{"lt":null,"ln":null},"followers":17462},"tweet_id":"383322971546607616"},{"url":"http:\/\/twitter.com\/BioWizzard\/status\/383323454940135424","license":"public","rt":["ScripMikeWard"],"citation_ids":[1783193],"posted_on":"2013-09-26T20:13:28+00:00","author":{"name":"Lee Stirling","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_0_normal.png","id_on_source":"BioWizzard","tweeter_id":"268836736","geo":{"lt":null,"ln":null},"followers":9},"tweet_id":"383323454940135424"},{"url":"http:\/\/twitter.com\/Editage\/status\/383067107958611969","license":"public","rt":["CMRO_Journal"],"citation_ids":[1783193],"posted_on":"2013-09-26T03:14:50+00:00","author":{"name":"Editage Insights","url":"http:\/\/editage.com\/insights","image":"https:\/\/pbs.twimg.com\/profile_images\/685334478059749376\/wMYtXxli_normal.jpg","description":"Engaging the #academic community with quality resources on all things #scholarlypublishing & #scicomm (Editor-in-Chief @ClarindaCerejo) https:\/\/t.co\/zUwey312yD","id_on_source":"Editage","tweeter_id":"78873087","geo":{"lt":null,"ln":null},"followers":2287},"tweet_id":"383067107958611969"},{"url":"http:\/\/twitter.com\/SummertownStars\/status\/383324625079652352","license":"public","rt":["ScripMikeWard"],"citation_ids":[1783193],"posted_on":"2013-09-26T20:18:07+00:00","author":{"name":"Summertown Stars","image":"http:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_5_normal.png","id_on_source":"SummertownStars","tweeter_id":"268851175","followers":18},"tweet_id":"383324625079652352"},{"url":"http:\/\/twitter.com\/CMRO_Journal\/status\/383092220758196224","license":"public","citation_ids":[1783193],"posted_on":"2013-09-26T04:54:37+00:00","author":{"name":"CMRO Medical Journal","url":"http:\/\/www.cmrojournal.com","image":"https:\/\/pbs.twimg.com\/profile_images\/474492886721896449\/Ja86fSwn_normal.jpeg","description":"Current Medical Research & Opinion - \nMEDLINE-indexed journal for rapid publication of clinical evidence","id_on_source":"CMRO_Journal","tweeter_id":"27037879","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":3540},"tweet_id":"383092220758196224"},{"url":"http:\/\/twitter.com\/scriptmedical\/status\/383222515029397504","license":"public","citation_ids":[1783193],"posted_on":"2013-09-26T13:32:22+00:00","author":{"name":"SCRIPT","url":"http:\/\/www.scriptmedical.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/3481116639\/04cd0fed17f00eaf8a4f5ac5f706200d_normal.jpeg","description":"Full-service medical communications company. \r\nCME | Healthcare advertising | Meeting design and facilitation | Medical publications | Tweets by @Dr_Janis","id_on_source":"scriptmedical","tweeter_id":"574757507","geo":{"lt":"43.6529206","ln":"-79.3849008","country":"CA"},"followers":67},"tweet_id":"383222515029397504"}]}}